Antigen-independent Th2 cell differentiation by stimulation of CD28: Regulation via IL-4 gene expression and mitogen-activated protein kinase activation

被引:39
作者
Skapenko, A
Lipsky, PE
Kraetsch, HG
Kalden, JR
Schulze-Koops, H
机构
[1] Univ Erlangen Nurnberg, Dept Internal Med 3, Clin Res Grp 3, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Inst Clin Immunol, D-91054 Erlangen, Germany
[3] NIAMSD, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.166.7.4283
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To delineate the molecular mechanisms regulating Th2 cell differentiation, CD28-mediated generation of Th2 effectors was analyzed. In the absence of TCR ligation CD28 stimulation induced Th2 differentiation of memory but not of naive CD4+ T cells, whereas costimulation via CD28 and the TCR enhanced Th2 differentiation from naive T cells but suppressed it from memory T cells. Stimulation of T cells via the CD28 pathway, therefore, provided critical signals facilitating Th2 cell differentiation. By comparing the responses to CD28 stimulation in memory and naive T cells and by using specific inhibitors, signaling pathways were defined that contributed to Th2 differentiation. CD28-induced Th2 differentiation required IL-4 stimulation and the activation of the mitogen-activated protein kinases p38 and extracellular signal-regulated kinases 1/2. CD28 engagement directly initiated IL-4 gene transcription in memory T cells and induced activation of phosphatidylinositol 3-kinase, p38, and c-Jun NH2-terminal kinase/stress-activated protein kinase pathways. Extracellular signal-regulated kinase phosphorylation that was necessary for Th2 differentiation, however, required stimulation by IL-2. These results indicate that optimal TCR-independent generation of Th2 effectors requires coordinate signaling via the CD28 and IL-2 pathways. TCR-independent generation of Th2 effectors might provide a mechanism to control Th1-dominated cellular inflammation.
引用
收藏
页码:4283 / 4292
页数:10
相关论文
共 56 条
[1]  
Alegre ML, 1996, J IMMUNOL, V157, P4762
[2]   CD28-B7 INTERACTIONS IN T-CELL ACTIVATION [J].
ALLISON, JP .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) :414-419
[3]  
Avraham A, 1998, EUR J IMMUNOL, V28, P2320, DOI 10.1002/(SICI)1521-4141(199808)28:08<2320::AID-IMMU2320>3.0.CO
[4]  
2-K
[5]   Helper T cell differentiation is controlled by the cell cycle [J].
Bird, JJ ;
Brown, DR ;
Mullen, AC ;
Moskowitz, NH ;
Mahowald, MA ;
Sider, JR ;
Gajewski, TF ;
Wang, CR ;
Reiner, SL .
IMMUNITY, 1998, 9 (02) :229-237
[6]  
Bischof A, 2000, EUR J IMMUNOL, V30, P876, DOI 10.1002/1521-4141(200003)30:3<876::AID-IMMU876>3.0.CO
[7]  
2-M
[8]   CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L) [J].
BOISE, LH ;
MINN, AJ ;
NOEL, PJ ;
JUNE, CH ;
ACCAVITTI, MA ;
LINDSTEN, T ;
THOMPSON, CB .
IMMUNITY, 1995, 3 (01) :87-98
[9]   Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein [J].
Brocke, S ;
Gijbels, K ;
Allegretta, M ;
Ferber, I ;
Piercy, C ;
Blankenstein, T ;
Martin, R ;
Utz, U ;
Karin, N ;
Mitchell, D ;
Veromaa, T ;
Waisman, A ;
Gaur, A ;
Conlon, P ;
Ling, N ;
Fairchild, PJ ;
Wraith, DC ;
OGarra, A ;
Fathman, CG ;
Steinman, L .
NATURE, 1996, 379 (6563) :343-346
[10]  
CERDAN C, 1992, J IMMUNOL, V149, P2255